论文信息 - Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor–Mutated Metastatic Non–Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722 - 字舞流文

Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor–Mutated Metastatic Non–Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722

J. Gainor | K. Ichikado | J. Sylvester | Yi‐Long Wu | Cheng-Ta Yang | Sunney Li | N. Girard | Hye Ryun Kim | Kazuhiko Nakagawa | Keunchil Park | Mengzhao Wang | Se-Hoon Lee | Chao-Hua Chiu | Sang-We Kim | J. Yang | Tony S K Mok | Y. Ohe | Chien Liang Wu | Lin Wu | Meng-Chih Lin | Jens Samol | Xiaoqing Zhang | Ann Forslund